NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/11/2023
Back to search
Official data from USPTO
AGIOS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
02/07/2025
Classification
Registered
Trademark type
Combined
Nice classes
5, 42
Filing date
11/02/2021
Registration date
04/11/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/11/2023
Last transaction
02/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/25/2022
First use in commerce
02/25/2022
Drawing code
3
Owner type
03
Owner location
Cambridge, MA
Examiner
OSBORNE, AUDRIANA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "agios" in a stylized format next to two intersecting arc designs.
Holders and representatives
Holders
Agios Pharmaceuticals, Inc.
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of genetically defined diseaseshematologic disorders and diseases related to aberrant cellular metabolism
Class 42
Providing pre-clinicalclinical and scientific research information in the field of pharmaceuticals including genetically defined diseaseshematologic disorders and diseases related to aberrant cellular metabolism
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/11/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/10/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/09/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/07/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/07/2023
IUAF
USE AMENDMENT FILED
02/19/2023
EISU
TEAS STATEMENT OF USE RECEIVED
02/19/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/23/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/28/2022
PUBO
PUBLISHED FOR OPPOSITION
06/28/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/08/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/20/2022
DOCK
ASSIGNED TO EXAMINER
05/19/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/09/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/09/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/12/2021
NWAP
NEW APPLICATION ENTERED
11/05/2021
Continuous trademark protection
Get notified about every new filing that threatens AGIOS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.